Clinical Trial

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to explore the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients (ypN+or supra/subclavicular lymph node positive) after neoadjuvant chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-14.
Trial Details
NCT Number NCT06559696
Lead Sponsor Fujian Medical University Union Hospital
Conditions Breast Cancer
Enrollment 722 participants
Start Date 2024-07-15
Primary Completion 2032-07-15 (estimated)
Study Completion 2032-07-15 (estimated)
Updated on ClinicalTrials.gov 2024-09-19